Aesculap

What Aesculap does

Aesculap, Inc. is the U.S. subsidiary of Germany's B. Braun group, manufacturing and selling surgical instruments, medical devices, and sterile processing solutions to U.S. hospitals, sterile processing departments (SPDs), and operating rooms (ORs). Founded in 1867 and headquartered in Center Valley, Pennsylvania, the company claims to be the world's largest surgical instrument manufacturer, with a portfolio spanning reusable and disposable surgical instruments, antibiotic-impregnated hydrocephalus catheters (XABO), bipolar forceps with 300+ configurations, rigid sterile container systems (SterilContainer), and real-time instrument tracking platforms (AESCULAP Aicon RTLS, SQ.track). Recent product launches (Aicon RTLS in April 2024, XABO catheters in June 2025, Irrigating Bipolar Forceps in October 2025) emphasize infection control, ergonomic precision, and digital asset management.

The business operates a direct enterprise sales model, selling quote-based to hospitals via phone, fax, email, and electronic ordering with net-30 terms, a $100 minimum order, and dedicated technical services and customer support lines. Revenue is generated primarily through hardware sales (surgical instruments and devices) and professional services (instrument repair, refurbishment, and on-site maintenance via repair vans and PODs). Aesculap markets through its corporate website, the Healthcare Insights Blog, the Aesculap Academy, annual industry benchmark reports (notably with Ascendco Health), and press releases, while distribution is anchored by a Hazelwood, Missouri warehouse and a direct sales representative network. Aesculap Implant Systems, LLC operates as a wholly-owned core subsidiary handling implant systems.

As a privately-held subsidiary within B. Braun, Aesculap does not disclose separate financial results, and growth is funded internally as part of the B. Braun family business. The company faces material risk from legacy legal exposure, including a $38.5 million Department of Justice settlement tied to defective knee replacement devices and surgeon kickbacks, and remains geographically limited to the United States through this entity.

Name

Aesculap

Legal name

Aesculap, Inc.

Website

https://aesculapusa.com

Company type

Private

Founded year

1867

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Aesculap, Inc. is the U.S. subsidiary of Germany's B. Braun group, manufacturing surgical instruments, neurosurgical devices, and sterile processing solutions for direct sale to U.S. hospitals, sterile processing departments, and operating rooms.

Ownership category

akta.pro rank

Product category

Surgical Instruments & Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)

akta.pro secondary industries

Sterilization Services & Contract Reprocessing (ETO/Gamma/E-beam providers) (HLAHANAB), Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM)

Keywords

• Surgical instruments
• Medical devices
• Sterile processing
• Neurosurgery equipment
• Surgical asset management

Headquarters

HQ city

Center Valley

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Surgical Instruments and Medical Devices: Aesculap generates revenue through the sale of surgical instruments, medical devices, and sterile processing equipment. The company offers both reusable and disposable products, including bipolar forceps, containers, and specialized surgical instruments.
2. Technical Services and Repairs: Aesculap provides repair and refurbishment services for surgical instruments and sterilization containers, including on-site repair van, POD, and in-house lab services. This includes preventative maintenance programs.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Aesculap manufactures and sells surgical instruments, medical devices, and sterile processing solutions for neurosurgery, general surgery, and hospital sterilization applications. Its portfolio includes reusable and disposable instruments (such as Yasargil-style and other bipolar forceps), neurosurgical implants like antibiotic-impregnated hydrocephalus catheters, rigid sterile container systems, and digital asset-tracking solutions including real-time location systems and cloud-based instrument tracking software. Offerings are sold to hospitals, sterile processing departments, and operating rooms through direct enterprise sales channels.

Differentiator

Problem solved

Functional benefit

Brands

• SQ.track: Cloud-based surgical instrument tracking software powered by Ascendco Health for real-time inventory visibility and compliance support.
• AESCULAP Aicon RTLS
• XABO
• SterilContainer
• QuickScan
• Yasargil

Products and services

• XABO Antibiotic-Impregnated Catheters Antibiotic-impregnated catheters for hydrocephalus treatment that continuously release clindamycin hydrochloride and rifampicin for a minimum of 38 days post-implantation; demonstrated two-thirds reduction in shunt infection rates. For neurosurgeons and hospitals performing hydrocephalus shunting procedures.
• Irrigating Specialty Non-Stick Disposable Bipolar Forceps Disposable bipolar forceps with non-stick tips, ergonomic handle design for precision and control, and 49% higher irrigation output than competitive dual irrigation systems. For surgeons using electrosurgical instruments across neurosurgery and other specialties.
• AESCULAP Aicon RTLS System Real-time location system integrating sterilizable Bluetooth beacons that automates tracking of surgical instrument trays across sterile processing and operating environments. For hospital sterile processing departments and operating rooms.
• SQ.track Instrument Tracking Software Cloud-based surgical instrument tracking software powered by Ascendco Health providing real-time location tracking, EMR compatibility, and compliance assistance for surgical asset management. For sterile processing departments and hospitals managing instrument fleets.
• SterilContainer System Rigid sterile container system made from 41% recycled aluminum, offering up to 80% cost and waste reduction compared to blue wrap, with over 10 FDA clearances. For hospital sterile processing departments replacing traditional wrap-based sterilization.
• Yasargil Bipolar Forceps Yasargil-style bipolar forceps widely used by surgeons worldwide for neurosurgical procedures, part of Aesculap's portfolio of over 300 bipolar forceps configurations. For neurosurgeons requiring precision bipolar instruments.
• Technical Services and Repairs Repair and refurbishment services for surgical instruments and sterilization containers, including on-site repair van, POD, and in-house lab services, plus preventative maintenance programs. For hospitals needing to maintain and extend the life of their surgical instrument fleets.
• Surgical Asset Management Solutions Integrated surgical asset management offerings combining AESCULAP Aicon RTLS, SQ.track software, SterilContainer systems, and QuickScan assessment tools with consulting on preference card cleanup, instrument set optimization, and reprocessing cost reduction. For sterile processing departments and operating rooms seeking end-to-end asset visibility.
• Aesculap Implant Systems Wholly-owned subsidiary Aesculap Implant Systems, LLC providing implant systems and medical devices. For hospitals and surgical centers using Aesculap implants.

Quantifiable outcome

• Two-thirds reduction in shunt infection rates compared to standard catheters
• +5 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature5 records

Partnerships

One partnership is on record.

• Ascendco HealthcoreStrategic or Co-development Partner · 6 November 2025Aesculap collaborated with Ascendco Health to release the 2025 Surgical Asset Management Industry Benchmark Report for the U.S. market. The partnership combined Aesculap's expertise in sterile processing and operating room solutions with Ascendco Health's surgical asset management platform to survey over 100 sterile processing and operating room leaders nationwide, revealing critical challenges impacting surgical readiness and patient safety.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Conmed Corporation: Medical device company focused on surgical instruments, electrosurgery (including bipolar forceps), and general surgery disposables. Directly comparable to Aesculap in bipolar forceps and surgical instrument categories serving OR customers.
• Steris plc: Leading provider of sterilization and infection prevention products and services to hospitals and SPDs. Directly competes with Aesculap's SterilContainer system and sterilization-focused offerings, serving the same sterile processing department customers.
• Getinge: Swedish medical technology company with surgical instruments, sterilization equipment, and OR integration solutions. Directly comparable to Aesculap in sterilization, surgical workflows, and instrument management, with similar hospital customer base.
• Integra LifeSciences: Specialty medical device company with strong neurosurgery and surgical instruments franchises. Closely aligned with Aesculap's neurosurgical focus and reusable instrument portfolio, serving the same neurosurgeon customer base.
• Becton, Dickinson and Company (BD): Major manufacturer of surgical instruments, sterilization products, and procedural devices. Directly comparable to Aesculap in surgical instrumentation and sterile processing consumables, serving similar hospital SPD and OR customers.

Broad incumbents

• Zimmer Biomet: Global orthopedic and surgical devices company. Relevant peer given Aesculap's Implant Systems subsidiary and prior DOJ knee implant settlement—overlaps in orthopedic surgical instruments and implant categories.
• Stryker Corporation: Large diversified medical device company with significant surgical instruments, OR equipment, and neurosurgery portfolios. Broad incumbent that competes with Aesculap across multiple instrument and equipment categories but serves a wider procedural footprint.
• Smith+Nephew: Diversified medical device company with surgical instruments, orthopedics, and wound management. Competes with Aesculap in surgical instruments and orthopedic adjacent categories, though broader portfolio and more sports medicine focus.
• Johnson & Johnson (Ethicon): Ethicon is J&J's surgical instruments and wound closure division, directly competing with Aesculap's reusable instruments, sutures, and surgical disposables. A broad incumbent with deeper portfolio breadth but similar hospital customer base.
• Medtronic plc: Global medical device leader with neurosurgery, surgical instruments, and patient monitoring portfolios. Direct competitor to Aesculap in neurosurgical devices and instruments, though Medtronic operates across many additional therapeutic areas.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/search
• LinkedInlinkedin.com/company/aesculap

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aesculap